Core Viewpoint - Warner Pharmaceuticals (688799.SH) has voluntarily withdrawn its drug registration application for Simethicone Emulsion, which is primarily used to alleviate discomfort caused by excessive gas in the gastrointestinal tract [1] Group 1: Company Actions - The company received a termination notice from the National Medical Products Administration (NMPA) regarding the drug registration application [1] - The decision to withdraw the application was made after careful consideration of the research and development strategy [1] Group 2: Product Information - Simethicone Emulsion is used for treating symptoms such as abdominal bloating and can also be utilized as an auxiliary medication for abdominal imaging examinations [1] - The product was initially submitted for market approval in January 2025 and had received acceptance from the NMPA [1]
华纳药厂(688799.SH):撤回药品注册申请